These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6787582)

  • 41. Hepatitis B prevalence and immunoprophylaxis with hepatitis B immunoglobulins in patients, relatives, and staff of a paediatric haemodialysis unit.
    Ghio L; Moroni GA; Piccoli P; Trombini M; Giani M; Angeli M; Edefonti A
    Helv Paediatr Acta; 1982; 37(1):17-26. PubMed ID: 7085327
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Epidemic focus of non-A, non-B viral hepatitis in a plasmapheresis unit].
    Laskus T; Cianciara J; Slusarczyk J
    Pol Tyg Lek; 1992 Mar 16-30; 47(11-13):254-6. PubMed ID: 1437724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Non-A, non-B hepatitis-related antigens and antibodies and experimental infection].
    Yoshizawa H
    Rinsho Byori; 1984 Nov; 32(11):1202-12. PubMed ID: 6084080
    [No Abstract]   [Full Text] [Related]  

  • 44. Causes of acute exacerbations of chronic hepatitis B.
    Stránský J; Benda R; Vodák M; Zikmundová L; Honzáková E
    Sb Lek; 1995; 96(2):75-83. PubMed ID: 8718791
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Non-A, Non-B hepatitis : status of current knowledge (authors' transl)].
    Sohier R; Trepo C
    Rev Epidemiol Sante Publique; 1980 Oct; 28(3):341-66. PubMed ID: 6781019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis.
    Esteve M; Saro C; González-Huix F; Suarez F; Forné M; Viver JM
    Gut; 2004 Sep; 53(9):1363-5. PubMed ID: 15306601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of hepatitis B, hepatitis C, and GB virus C/hepatitis G virus infections in liver disease patients and inhabitants in Ho Chi Minh, Vietnam.
    Kakumu S; Sato K; Morishita T; Trinh KA; Nguyen HB; Banh VD; Do HC; Nguyen HP; Nguyen VT; Le TT; Yamamoto N; Nakao H; Isomura S
    J Med Virol; 1998 Apr; 54(4):243-8. PubMed ID: 9557289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of non A, non B hepatitis: the problem and its treatment.
    Thomas HC; Jacyna MR; Main J
    Chemioterapia; 1988 Dec; 7 Suppl 3():30-4. PubMed ID: 3150301
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Viral hepatitis in Bucharest.
    Paquet C; Babes VT; Drucker J; Sénémaud B; Dobrescu A
    Bull World Health Organ; 1993; 71(6):781-6. PubMed ID: 8313496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Researches on viral hepatitis markers correlated with pathomorphological and clinical aspects in chronic hepatitis.
    Brehar-Cioflec D; Vajda A; Negrea DA; Străin R; Tudose N; Sporea I; Moldovan R; Chidioşan C; Chirileanu O; Gaiţă-Criveanu D
    Rom J Virol; 1995; 46(3-4):107-13. PubMed ID: 9179963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of hepatitis B virus in non-B, non-C chronic liver disease: in vitro proliferation and interferon-gamma production of peripheral blood mononuclear cells in response to hepatitis B core antigen and its relation to hepatitis activity.
    Niigaki M; Fukuda R; Hamamoto S; Ishimura N; Ishihara S; Akagi S; Watanabe M; Kinoshita Y
    Am J Gastroenterol; 2000 Jan; 95(1):239-47. PubMed ID: 10638591
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hepatopathy and hepatitis B virus infection in dialysis patients: cross-sectional study].
    Fabrizi F; Bisegna S; Mangano S; Alongi G; Colucci P; Finazzi S; De Vecchi AF; Ponticelli C
    G Ital Nefrol; 2002; 19(2):149-54. PubMed ID: 12195413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Immunopathogenesis and immunopathology of acute viral hepatitis (author's transl)].
    Arnold W
    Acta Med Austriaca; 1981; 7(2):33-7. PubMed ID: 6782811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hepatitis caused by cytomegalovirus].
    Panizo Delgado A; García de Jalón J
    Rev Med Univ Navarra; 1981 Mar; 25(1):33-9. PubMed ID: 6278554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Detection of antigenic markers in non-A, non-B viral hepatitis].
    Shimizu M; Ohyama M; Saito M; Muto Y; Takahashi Y
    Nihon Rinsho; 1981 Oct; 39(10):3209-15. PubMed ID: 6803018
    [No Abstract]   [Full Text] [Related]  

  • 57. Specificity and significance of hepatocellular ultrastructural changes in non-A, non-B hepatitis in chimpanzees.
    Brotman B; Prince AM; Huima T; Richardson L; Pfeifer U
    Dev Biol Stand; 1983; 54():451-62. PubMed ID: 6418590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An enzyme-linked immunoassay for the possible detection of non-A, non-B viral antigen in patients with epidemic viral hepatitis.
    Gupta H; Joshi YK; Tandon BN
    Liver; 1988 Apr; 8(2):111-5. PubMed ID: 2452952
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The clinical behaviour of by immunology unique courses of NANB hepatitis (author's transl)].
    Liehr H; Seelig R; Seelig HP
    Z Gastroenterol; 1982 May; 20(5):278-85. PubMed ID: 6125065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis markers in a psychiatric institution.
    Gmelin K; Doerr HW; Middelhoff H; von Ehrlich B; Sann G; Theilmann G; Kommerell B
    Dev Biol Stand; 1983; 54():545-8. PubMed ID: 6653899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.